%0 Journal Article %T Myasthenia gravis as a prognostic marker in patients with thymoma %A Cacho-Díaz, Bernardo %A Salmerón-Moreno, Karen %A Lorenzana-Mendoza, Nydia A. %A Texcocano, Julia %A Arrieta, Oscar %J Journal of Thoracic Disease %D 2018 %B 2018 %9 %! Myasthenia gravis as a prognostic marker in patients with thymoma %K %X Background: Thymoma is the most common mediastinal tumor, representing Methods: A retrospective 10-year database of the patients with thymoma treated at a single cancer referral hospital (National Institute of Cancer, Mexico City), was analyzed. Results: Sixty-four files from patients with thymoma were analyzed, 18 of them had MG. The symptoms that occurred most frequently in patients with MG were ptosis, diplopia, appendicular weakness, dysphonia and dysphagia. The most frequent Myasthenia Gravis Foundation of America (MGFA) stage was IIIb followed by stage I. Almost all the patients with MG had positive Acetylcholine Receptor antibodies (P Conclusions: In patients with thymoma MG manifests with different clinical and autoimmune traits, but not survival differences. A larger multi-centric study should be encouraged to evaluate the prognostic implications of having MG in patients with thymoma. %U https://jtd.amegroups.org/article/view/21111 %V 10 %N 5 %P 2842-2848 %@ 2077-6624